Split 3rd Circ. Rejects Janssen, Bristol Myers Pricing Appeal
By Hailey Konnath · September 4, 2025, 11:29 PM EDT
A split Third Circuit panel Thursday shot down another challenge to the Medicare drug pricing negotiation, this time rejecting a consolidated appeal from Bristol Myers Squibb and Janssen and upholding a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login